Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1983 3
1984 3
1986 2
1987 2
1988 2
1989 1
1990 3
1991 6
1992 2
1993 6
1994 5
1995 3
1996 6
1997 4
1998 4
1999 7
2000 10
2001 6
2002 4
2003 1
2004 7
2005 4
2006 9
2007 5
2008 4
2009 8
2010 8
2011 3
2012 6
2013 8
2014 4
2015 5
2016 7
2017 10
2018 6
2019 5
2020 4
2021 6
2022 4
2023 4

Text availability

Article attribute

Article type

Publication date

Search Results

183 results

Results by year

Filters applied: . Clear all
Page 1
Dietary Supplement Use During Chemotherapy and Survival Outcomes of Patients With Breast Cancer Enrolled in a Cooperative Group Clinical Trial (SWOG S0221).
Ambrosone CB, Zirpoli GR, Hutson AD, McCann WE, McCann SE, Barlow WE, Kelly KM, Cannioto R, Sucheston-Campbell LE, Hershman DL, Unger JM, Moore HCF, Stewart JA, Isaacs C, Hobday TJ, Salim M, Hortobagyi GN, Gralow JR, Budd GT, Albain KS. Ambrosone CB, et al. Among authors: budd gt. J Clin Oncol. 2020 Mar 10;38(8):804-814. doi: 10.1200/JCO.19.01203. Epub 2019 Dec 19. J Clin Oncol. 2020. PMID: 31855498 Free PMC article. Clinical Trial.
Physical Activity Before, During, and After Chemotherapy for High-Risk Breast Cancer: Relationships With Survival.
Cannioto RA, Hutson A, Dighe S, McCann W, McCann SE, Zirpoli GR, Barlow W, Kelly KM, DeNysschen CA, Hershman DL, Unger JM, Moore HCF, Stewart JA, Isaacs C, Hobday TJ, Salim M, Hortobagyi GN, Gralow JR, Albain KS, Budd GT, Ambrosone CB. Cannioto RA, et al. Among authors: budd gt. J Natl Cancer Inst. 2021 Jan 4;113(1):54-63. doi: 10.1093/jnci/djaa046. J Natl Cancer Inst. 2021. PMID: 32239145 Free PMC article.
Multicenter phase II trial (SWOG S1609, cohort 51) of ipilimumab and nivolumab in metastatic or unresectable angiosarcoma: a substudy of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors (DART).
Wagner MJ, Othus M, Patel SP, Ryan C, Sangal A, Powers B, Budd GT, Victor AI, Hsueh CT, Chugh R, Nair S, Leu KM, Agulnik M, Sharon E, Mayerson E, Plets M, Blanke C, Streicher H, Chae YK, Kurzrock R. Wagner MJ, et al. Among authors: budd gt. J Immunother Cancer. 2021 Aug;9(8):e002990. doi: 10.1136/jitc-2021-002990. J Immunother Cancer. 2021. PMID: 34380663 Free PMC article. Clinical Trial.
Can CDK4/6 inhibitors cause fatal lung injury?
Jazieh KA, Budd GT, Dalpiaz N, Abraham J. Jazieh KA, et al. Among authors: budd gt. Expert Rev Anticancer Ther. 2019 Nov;19(11):917-919. doi: 10.1080/14737140.2019.1674651. Epub 2019 Oct 8. Expert Rev Anticancer Ther. 2019. PMID: 31566017 No abstract available.
Management of angiosarcoma.
Budd GT. Budd GT. Curr Oncol Rep. 2002 Nov;4(6):515-9. doi: 10.1007/s11912-002-0066-3. Curr Oncol Rep. 2002. PMID: 12354365 Review.
E2112: Randomized Phase III Trial of Endocrine Therapy Plus Entinostat or Placebo in Hormone Receptor-Positive Advanced Breast Cancer. A Trial of the ECOG-ACRIN Cancer Research Group.
Connolly RM, Zhao F, Miller KD, Lee MJ, Piekarz RL, Smith KL, Brown-Glaberman UA, Winn JS, Faller BA, Onitilo AA, Burkard ME, Budd GT, Levine EG, Royce ME, Kaufman PA, Thomas A, Trepel JB, Wolff AC, Sparano JA. Connolly RM, et al. Among authors: budd gt. J Clin Oncol. 2021 Oct 1;39(28):3171-3181. doi: 10.1200/JCO.21.00944. Epub 2021 Aug 6. J Clin Oncol. 2021. PMID: 34357781 Free PMC article. Clinical Trial.
Levison AL, Erenler F, Zhao Y, Martin DF, Lowder C, Budd GT, Singh AD. Levison AL, et al. Among authors: budd gt. Retin Cases Brief Rep. 2018 Fall;12(4):342-345. doi: 10.1097/ICB.0000000000000516. Retin Cases Brief Rep. 2018. PMID: 28045860
Interleukin-2: use in solid tumors.
Bukowski RM, McLain D, Olencki T, Budd GT, Murthy SA. Bukowski RM, et al. Among authors: budd gt. Stem Cells. 1993 Jan;11(1):26-32. doi: 10.1002/stem.5530110106. Stem Cells. 1993. PMID: 8457777 Review.
183 results